Algaehealth

Algae Health Sciences gets NDI for high dose astaxanthin

Algae Health Sciences gets NDI for high dose astaxanthin

By Stephen Daniells

The US Food and Drug Administration has accepted a New Dietary Ingredient (NDI) notification from Algae Health Sciences, Inc., a subsidiary of BGG, for high-dose but limited duration astaxanthin dosing.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All